Malte Greune, Founder of CureVac

Malte Greune is the founder of CureVac. CureVac has raised $975M in total funding. Latest round: Series F. Based in Tübingen, Germany.

About Malte Greune

Malte Greune is the Chief Operating Officer (COO) at CureVac, a clinical-stage biopharmaceutical company focused on developing transformative medicines using messenger ribonucleic acid (mRNA). Appointed to this role on July 1, 2021, he is responsible for strengthening the company's Management Board and overseeing its clinical and commercial manufacturing activities. Greune brings extensive experience from the global pharmaceutical industry, including manufacturing vaccines and biologics. Before joining CureVac, he held various management positions at Sanofi-Aventis Deutschland GmbH for nearly ten years, where he was responsible for several manufacturing sites.

Malte Greune at a glance

More founders in Tübingen, Germany (28)

Browse related founder lists (6)

Full founder directory · Investor directory · Company funding database · Fundraising library

Resources
Join free
Sign Out Dashboard

The Startup Fundraising Platform

Raise funds for your startup

Find the right investors and get real replies — instantly, powered by AI.

  • AI-scored pitch deck
  • Matched investor list
  • Personalized outreach drafts
Join for free

Takes 30 seconds · No credit card · Cancel anytime

See it in action ↓
  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
  • All
  • Seed & Pre-Seed
  • Series A & B
  • Fintech
  • SaaS & Dev Tools
  • Consumer & Social
  • Marketplace & Frontier
  • Mistakes to Avoid
  • Checklist
  • How to Send
  • Design
  • Length
  • Order
  • Storytelling
  • Investor Q&A
  • One-Pager
  • Email Templates
  • Data Room
  • Investor Update
  • Term Sheet
  • SAFE vs Priced
  • Due Diligence
  • Timeline
  • Metrics
  • Valuation
  • Cap Table
  • Pipeline
  • Board
  • Objections
  • References
  • Closing
  • Bridge Round
  • Down Round
  • Secondary Sale
  • Investor Rejection
  • First Meeting
  • Second Meeting
  • Partner Meeting
  • Post-Mortem
  • Update Cadence
  • Angel Round
  • Option Pool Shuffle
  • Fundraise Pause
  • Vetting VCs
  • First 90 Days
  • First Board Meeting
  • Reference Calls
  • NDA Template
  • Bylaws Template
LibraryPitch Deck Examples

Slide-by-slide guide

 

  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
LibraryArticles

•By Alejandro Cremades